NIH-funded research R15 grant

How the body's internal clock affects diet and aging in fruit flies

Official title: Genetic Mechanisms of Circadian Clock-Mediated Dietary Restriction in Drosophila

Funded at University of Louisville · NIH-10579030 · Data updated 2026-11-12

This study is looking at how eating less food without missing out on nutrients can help us live longer and healthier, using fruit flies to understand how our body’s internal clock and diet work together to affect our health.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startFebruary 1, 2023
Project endJanuary 31, 2026
Funding year2023
Award (this year)$445,390
NIH project number1R15AG074538-01A1
Project IDNIH-10579030 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research would be individuals interested in dietary interventions for aging and health promotion.

Less likely to help

Patients with conditions that prevent them from participating in dietary changes or those not interested in dietary interventions may not benefit from this research.

What this research studies

This research investigates how dietary restriction, which involves reducing calorie intake without causing malnutrition, can extend lifespan and improve health. Using fruit flies as a model organism, the study aims to uncover the genetic mechanisms by which the circadian clock interacts with diet and light cycles to influence metabolism and behavior. By employing advanced genetic tools and various assays, researchers will explore how these interactions can promote longevity and overall health.

Why it matters

Potential benefit: If successful, this research could lead to new insights into dietary strategies that enhance health and longevity in humans.

How similar studies have gone: Previous research has shown that dietary restriction can extend lifespan in various organisms, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Hwangbo, Dae-Sung — University of Louisville
  • Study coordinator: Hwangbo, Dae-Sung

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.